These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19192982)

  • 1. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences.
    Mathias SD; Gao SK; Rutstein M; Snyder CF; Wu AW; Cella D
    Curr Med Res Opin; 2009 Feb; 25(2):375-83. PubMed ID: 19192982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Health Qual Life Outcomes; 2007 Feb; 5():11. PubMed ID: 17316442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
    George JN; Mathias SD; Go RS; Guo M; Henry DH; Lyons R; Redner RL; Rice L; Schipperus MR
    Br J Haematol; 2009 Feb; 144(3):409-15. PubMed ID: 19016720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.
    Snyder CF; Mathias SD; Cella D; Isitt JJ; Wu AW; Young J
    Curr Med Res Opin; 2008 Oct; 24(10):2767-76. PubMed ID: 18715526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
    Kuter DJ; Mathias SD; Rummel M; Mandanas R; Giagounidis AA; Wang X; Deuson RR
    Am J Hematol; 2012 May; 87(5):558-61. PubMed ID: 22460421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in adult primary immune thrombocytopenia.
    Sestøl HG; Trangbæk SM; Bussel JB; Frederiksen H
    Expert Rev Hematol; 2018 Dec; 11(12):975-985. PubMed ID: 30444433
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of ITP on physician visits and workplace productivity.
    Tarantino MD; Mathias SD; Snyder CF; Isitt JJ; Gernsheimer T; Young J
    Curr Med Res Opin; 2010 Feb; 26(2):319-28. PubMed ID: 19968458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenic purpura: epidemiology and implications for patients.
    Michel M
    Eur J Haematol Suppl; 2009 Mar; (71):3-7. PubMed ID: 19200301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).
    Klaassen RJ; Mathias SD; Buchanan G; Bussel J; Deuson R; Young NL; Collier A; Bomgaars L; Blanchette V
    Pediatr Blood Cancer; 2012 Mar; 58(3):395-8. PubMed ID: 21910213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China.
    Zhang W; Xie S; Fu R; Chen Y; Liu W; Sun T; Ju M; Li H; Xue F; Zhang L; Liu X; Yang R
    Expert Rev Hematol; 2023; 16(12):1125-1133. PubMed ID: 38009277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
    Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
    Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP).
    Sanz MA; Aledort L; Mathias SD; Wang X; Isitt JJ
    Value Health; 2011 Jan; 14(1):90-6. PubMed ID: 21211490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in children with chronic immune thrombocytopenia in China.
    Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
    Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
    Yost KJ; Sorensen MV; Hahn EA; Glendenning GA; Gnanasakthy A; Cella D
    Value Health; 2005; 8(2):117-27. PubMed ID: 15804320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT).
    van der Maas NA
    BMC Neurol; 2017 Mar; 17(1):50. PubMed ID: 28302081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.
    Rüfer A; Terrell DR
    Br J Haematol; 2023 Oct; 203(1):79-85. PubMed ID: 37735553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL).
    von Mackensen S; Nilsson C; Jankovic M; Mirra N; D'Angelo E; Borkhardt A; Ljung R
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):688-91. PubMed ID: 16933256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.